• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子抑制剂修饰的α-突触核蛋白部分肽特异性抑制α-突触核蛋白的淀粉样纤维形成。

Partial peptide of α-synuclein modified with small-molecule inhibitors specifically inhibits amyloid fibrillation of α-synuclein.

机构信息

Department of Biotechnology, Graduate School of Engineering, Tokyo University of Agriculture & Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.

出版信息

Int J Mol Sci. 2013 Jan 28;14(2):2590-600. doi: 10.3390/ijms14022590.

DOI:10.3390/ijms14022590
PMID:23358249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3588004/
Abstract

We have previously reported that pyrroloquinoline quinone (PQQ) prevents the amyloid formation of α-synuclein, amyloid β(1-42) (Aβ(1-42)), and mouse prion protein. Moreover, PQQ-modified α-synuclein and a proteolytic fragment of the PQQ-modified α-synuclein are able to inhibit the amyloid formation of α-synuclein. Here, we identified the peptide sequences that play an important role as PQQ-modified specific peptide inhibitors of α-synuclein. We demonstrate that the PQQ-modified α-Syn(36-46) peptide, which is a partial sequence of α-synuclein, prevented α-synuclein amyloid fibril formation but did not inhibit Aβ(1-42) fibril formation. In addition, the α-synuclein partial peptide modified with other small-molecule inhibitors, Baicalein and epigallocatechin gallate (EGCG), prevented α-synuclein fibril formation. Currently reported quinone amyloid inhibitors do not have selectivity toward protein molecules. Therefore, our achievements provide a novel strategy for the development of targeted specific amyloid formation inhibitors: the combination of quinone compounds with specific peptide sequence from target proteins involved in amyloid formation.

摘要

我们之前曾报道过吡咯并喹啉醌(PQQ)可防止α-突触核蛋白、淀粉样β(1-42)(Aβ(1-42))和鼠朊蛋白的淀粉样形成。此外,PQQ 修饰的α-突触核蛋白和 PQQ 修饰的α-突触核蛋白的蛋白水解片段能够抑制α-突触核蛋白的淀粉样形成。在这里,我们鉴定了作为 PQQ 修饰的α-突触核蛋白特异性肽抑制剂起重要作用的肽序列。我们证明,PQQ 修饰的α-Syn(36-46)肽是α-突触核蛋白的部分序列,可防止α-突触核蛋白淀粉样纤维形成,但不抑制 Aβ(1-42)纤维形成。此外,用其他小分子抑制剂白杨素和表没食子儿茶素没食子酸酯(EGCG)修饰的α-突触核蛋白部分肽也可防止α-突触核蛋白纤维形成。目前报道的醌类淀粉样抑制剂对蛋白质分子没有选择性。因此,我们的研究成果为开发靶向特定淀粉样形成抑制剂提供了新策略:将醌类化合物与参与淀粉样形成的靶蛋白的特定肽序列相结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/8ca44977e605/ijms-14-02590f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/4b45f39ea05a/ijms-14-02590f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/ef45718adfcf/ijms-14-02590f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/58cb1c9f4aac/ijms-14-02590f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/8ca44977e605/ijms-14-02590f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/4b45f39ea05a/ijms-14-02590f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/ef45718adfcf/ijms-14-02590f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/58cb1c9f4aac/ijms-14-02590f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/3588004/8ca44977e605/ijms-14-02590f4.jpg

相似文献

1
Partial peptide of α-synuclein modified with small-molecule inhibitors specifically inhibits amyloid fibrillation of α-synuclein.小分子抑制剂修饰的α-突触核蛋白部分肽特异性抑制α-突触核蛋白的淀粉样纤维形成。
Int J Mol Sci. 2013 Jan 28;14(2):2590-600. doi: 10.3390/ijms14022590.
2
Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.吡咯喹啉醌(PQQ)可防止α-突触核蛋白的原纤维形成。
Biochem Biophys Res Commun. 2006 Oct 27;349(3):1139-44. doi: 10.1016/j.bbrc.2006.08.144. Epub 2006 Sep 1.
3
Esterification of PQQ Enhances Blood-Brain Barrier Permeability and Inhibitory Activity against Amyloidogenic Protein Fibril Formation.PQQ 的酯化作用可增强血脑屏障通透性并抑制淀粉样蛋白原纤维的形成。
ACS Chem Neurosci. 2018 Dec 19;9(12):2898-2903. doi: 10.1021/acschemneuro.8b00355. Epub 2018 Aug 8.
4
Electrochemical flow injection analysis of the interaction between pyrroloquinoline quinone (PQQ) and α-synuclein peptides related to Parkinson's disease.电化学流动注射分析吡咯喹啉醌 (PQQ) 与帕金森病相关的α-突触核蛋白肽的相互作用。
Analyst. 2021 Jul 21;146(14):4545-4556. doi: 10.1039/d1an00698c. Epub 2021 Jun 18.
5
Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation.黄芩素抑制活细胞内α-突触核蛋白寡聚体的形成,并防止 Aβ 肽纤维形成和寡聚化。
Chembiochem. 2011 Mar 7;12(4):615-24. doi: 10.1002/cbic.201000604. Epub 2011 Jan 26.
6
The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein.吡咯并喹啉醌对截短的α-突触核蛋白淀粉样形成和细胞毒性的抑制作用。
Mol Neurodegener. 2010 May 20;5:20. doi: 10.1186/1750-1326-5-20.
7
Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins.吡咯并喹啉醌抑制淀粉样蛋白的纤维形成。
Prion. 2010 Jan-Mar;4(1):26-31. doi: 10.4161/pri.4.1.10889. Epub 2010 Jan 4.
8
Understanding the Inhibitory and Antioxidant Effects of Pyrroloquinoline Quinone (PQQ) on Copper(II)-Induced α-Synuclein-119 Aggregation.了解吡咯并喹啉醌 (PQQ) 对铜 (II)诱导的 α-突触核蛋白-119 聚集的抑制和抗氧化作用。
ACS Chem Neurosci. 2022 Apr 20;13(8):1178-1186. doi: 10.1021/acschemneuro.1c00703. Epub 2022 Apr 12.
9
The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of -Synuclein Amyloid Fibril Formation.聚合条件决定 EGCG 是 α-突触核蛋白淀粉样纤维形成的抑制剂还是增强剂。
Int J Mol Sci. 2020 Mar 14;21(6):1995. doi: 10.3390/ijms21061995.
10
Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).寡肽介导的β淀粉样蛋白(Aβ)和α-突触核蛋白片段肽(NAC)淀粉样纤维形成的加速作用
J Pept Sci. 2004 Jan;10(1):8-17. doi: 10.1002/psc.485.

引用本文的文献

1
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease.天然产物在帕金森病治疗中抑制α-突触核蛋白异常聚集的潜力。
Front Pharmacol. 2024 Oct 23;15:1468850. doi: 10.3389/fphar.2024.1468850. eCollection 2024.
2
Polyphenol-based polymer nanoparticles for inhibiting amyloid protein aggregation: recent advances and perspectives.用于抑制淀粉样蛋白聚集的基于多酚的聚合物纳米颗粒:最新进展与展望
Front Nutr. 2024 Jul 29;11:1408620. doi: 10.3389/fnut.2024.1408620. eCollection 2024.
3
Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease.

本文引用的文献

1
A novel inhibitor of amyloid β (Aβ) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease.一种新型的淀粉样β(Aβ)肽聚集抑制剂:从高通量筛选到阿尔茨海默病动物模型中的疗效。
J Biol Chem. 2012 Nov 9;287(46):38992-9000. doi: 10.1074/jbc.M112.348037. Epub 2012 Sep 19.
2
Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.调节淀粉样蛋白的自组装作为神经退行性疾病的治疗方法:策略和机制。
ChemMedChem. 2012 Mar 5;7(3):359-74. doi: 10.1002/cmdc.201100585. Epub 2012 Feb 9.
3
Inhibition of amyloid formation.
基于肽的方法直接靶向帕金森病中的 alpha-synuclein。
Mol Neurodegener. 2023 Nov 9;18(1):80. doi: 10.1186/s13024-023-00675-8.
4
Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases.绿茶多酚表没食子儿没食子酸酯在淀粉样蛋白聚集和神经退行性疾病中的作用
Front Neurosci. 2021 Sep 14;15:718188. doi: 10.3389/fnins.2021.718188. eCollection 2021.
5
Nutraceuticals: An integrative approach to starve Parkinson's disease.营养保健品:一种对抗帕金森病的综合方法。
Brain Behav Immun Health. 2020 Jan 16;2:100037. doi: 10.1016/j.bbih.2020.100037. eCollection 2020 Feb.
6
Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection.表没食子儿茶素没食子酸酯载脂微球有利于小胶质细胞抗炎和促进神经保护。
Int J Mol Sci. 2021 Mar 16;22(6):3037. doi: 10.3390/ijms22063037.
7
Plant Extracts and Phytochemicals Targeting -Synuclein Aggregation in Parkinson's Disease Models.针对帕金森病模型中α-突触核蛋白聚集的植物提取物和植物化学物质
Front Pharmacol. 2019 Mar 19;9:1555. doi: 10.3389/fphar.2018.01555. eCollection 2018.
8
"Cell-addictive" dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway.通过 flotillins 通路治疗帕金森病的“细胞成瘾”双靶标示踪纳米药物。
Theranostics. 2018 Oct 29;8(19):5469-5481. doi: 10.7150/thno.28295. eCollection 2018.
9
Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease.表没食子儿茶素没食子酸酯(EGCG)抑制α-突触核蛋白聚集:一种治疗帕金森病的潜在药物。
Neurochem Res. 2016 Oct;41(10):2788-2796. doi: 10.1007/s11064-016-1995-9. Epub 2016 Jun 30.
淀粉样蛋白形成的抑制
J Mol Biol. 2012 Aug 24;421(4-5):441-65. doi: 10.1016/j.jmb.2011.12.062. Epub 2012 Jan 5.
4
Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.致力于发现有效的α-突触核蛋白淀粉样组装多环抑制剂。
J Biol Chem. 2011 Sep 16;286(37):32036-44. doi: 10.1074/jbc.M111.242958. Epub 2011 Jul 27.
5
Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization.人血清白蛋白在(-)-表没食子儿茶素没食子酸酯氧化过程中作为抗氧化剂:可逆共价结合参与相互作用和稳定作用。
Biosci Biotechnol Biochem. 2011;75(1):100-6. doi: 10.1271/bbb.100600. Epub 2011 Jan 7.
6
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.表儿茶素没食子酸酯(-)-表没食子儿茶素 3-没食子酸酯可抑制胰岛淀粉样多肽的淀粉样纤维形成,解聚淀粉样纤维,并可防止 IAPP 诱导的细胞毒性。
Biochemistry. 2010 Sep 21;49(37):8127-33. doi: 10.1021/bi100939a.
7
The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation.硫酸三苯甲烷衍生物酸性品红是一种有效的人胰岛淀粉样多肽形成的抑制剂,并能防止淀粉样形成的毒性作用。
J Mol Biol. 2010 Jul 16;400(3):555-66. doi: 10.1016/j.jmb.2010.05.001. Epub 2010 May 7.
8
Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins.吡咯并喹啉醌抑制淀粉样蛋白的纤维形成。
Prion. 2010 Jan-Mar;4(1):26-31. doi: 10.4161/pri.4.1.10889. Epub 2010 Jan 4.
9
Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.酪氨酸突变为丙氨酸对α-突触核蛋白纤维化及结构特性的影响。
Biochim Biophys Acta. 2008 Oct;1782(10):581-5. doi: 10.1016/j.bbadis.2008.07.004. Epub 2008 Jul 22.
10
The fold of alpha-synuclein fibrils.α-突触核蛋白原纤维的折叠
Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8637-42. doi: 10.1073/pnas.0712179105. Epub 2008 Jun 12.